CM-336 BCMA/CD3 bispecific antibody
IIT2024012
Unknown small_molecule terminated
Quick answer
CM-336 BCMA/CD3 bispecific antibody for AL Amyloidosis is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- AL Amyloidosis
- Phase
- Unknown
- Modality
- small_molecule
- Status
- terminated